FINEARTS HF Poster Meeting at HFSA 2024

Invitation Only

1. Obtain first-hand expert’s opinions and feedback on the FINEARTS-HF and FINEHEART sub-analysis presented/published at HFSA (i.e. across LVEF, age, baseline HF medication, KCCQ, NYHA Class, and recency of HF event). 
2. Obtain first-hand expert’s opinions and feedback on the MRA meta-analysis. 
3. Collect insights on the implications of the new finerenone data for clinical practice. 
4. Gather experiences and insights from investigators who have used finerenone in HF. 
5. Engage HCPs on Bayer’s commitment to heart failure care, upcoming heart failure projects, and other newly released data at HFSA. 
6. Gain insights on Bayer’s HF Clinical Research Program.